Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.

por Gundersen, S., Aamdal, S., Fodstad, O.
Publicado 1987

Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.

por Fodstad, O., Olsnes, S., Pihl, A.
Publicado 1976

Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.

por Myklebust, A. T., Pharo, A., Fodstad, O.
Publicado 1993

An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.

por Fodstad, O., Aass, N., Pihl, A.
Publicado 1980

Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo

por Andersson, Y, Engebraaten, O, Fodstad, Ø
Publicado 2009

Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

por Kjønniksen, I., Rye, P. D., Fodstad, O.
Publicado 1994

Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice

por Thies, A, Mauer, S, Fodstad, O, Schumacher, U
Publicado 2007

Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein Bim(EL) and induces apoptosis

por Lund, T, Stokke, T, Olsen, Ø E, Fodstad, Ø
Publicado 2005

Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

por Aamdal, S., Fodstad, O., Nesland, J. M., Pihl, A.
Publicado 1985

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.

por Bruland, O., Fodstad, O., Skretting, A., Pihl, A.
Publicado 1987

A human melanoma cell line established from xenograft in athymic mice.

por Tveit, K. M., Fodstad, O., Johannessen, J. V., Olsnes, S.
Publicado 1980

Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells.

por Godal, A., Bruland, O., Haug, E., Aas, M., Fodstad, O.
Publicado 1986

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies

por Pedersen, K B, Nesland, J M, Fodstad, Ø, Mælandsmo, G M
Publicado 2002

Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and in...

por Engebraaten, O, Hjortland, GO, Martinsen, M, Halvorsen, T, Fodstad, Ø, Ree, AH
Publicado 2005

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin

por Andersson, Y, Engebraaten, O, Juell, S, Aamdal, S, Brunsvig, P, Fodstad, Ø, Dueland, S
Publicado 2015

Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.

por Tveit, K. M., Endresen, L., Rugstad, H. E., Fodstad, O., Pihl, A.
Publicado 1981

TP53 allele loss, mutations and expression in malignant melanoma.

por Flørenes, V. A., Oyjord, T., Holm, R., Skrede, M., Børresen, A. L., Nesland, J. M., Fodstad, O.
Publicado 1994

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.

por Maelandsmo, G. M., Berner, J. M., Flørenes, V. A., Forus, A., Hovig, E., Fodstad, O., Myklebost, O.
Publicado 1995

Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.

por Forus, A., Berner, J. M., Meza-Zepeda, L. A., Saeter, G., Mischke, D., Fodstad, O., Myklebost, O.
Publicado 1998

Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrest

por Andersen, K, Smith-Sørensen, B, Pedersen, K B, Hovig, E, Myklebost, O, Fodstad, Ø, Mælandsmo, G M
Publicado 2003